VIATREXX-FACIAL- adrenal, collagen, cutis, diosorea, epithelial growth factor, erythrocytes, fumaric acid, funiculus, gingko, hy

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

Sus Scrofa Adrenal Gland (UNII: 398IYQ16YV) (Sus Scrofa Adrenal Gland - UNII:398IYQ16YV), Bos Taurus Adrenal Gland (UNII: M2776SWB29) (Bos Taurus Adrenal Gland - UNII:M2776SWB29), Pork Collagen (UNII: I8442U2G7J) (Pork Collagen - UNII:I8442U2G7J), Cuminaldehyde (UNII: O0893NC35F) (Cuminaldehyde - UNII:O0893NC35F), Dioscorea Villosa Tuber (UNII: IWY3IWX2G8) (Dioscorea Villosa Tuber - UNII:IWY3IWX2G8), Sus Scrofa Red Blood Cell (UNII: 5X23IGF970) (Sus Scrofa Red Blood Cell - UNII:5X23IGF970), Bos Taurus Red B

Available from:

VIATREXX BIO INCORPORATED

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Viatrexx-Facial a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, muscles, ligaments, joints, other body tissues or added to an IV, either as a push or into the bag. This product should not be used in patients with a known hypersensitivity to any ingredient found in the formula, porcine products, isotonic saline or benzyl alcohol, or patients with a history of severe allergies. As with all injections, epinephrine injection (1:1,000) must be immediately available should an acute anaphylactoid reaction occur due to any component of the injection. This product contains 1% Benzyl Alcohol. Benzyl Alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants. Due to the benzyl alcohol content, this product should not be given to a pregnant woman. This product should not be used in patients with a known hypersensitivity to any ingredient in this formula, porcine products, isotonic saline or benzyl alcohol, or patients

Authorization status:

unapproved drug other

Summary of Product characteristics

                                VIATREXX-FACIAL- ADRENAL, COLLAGEN, CUTIS, DIOSOREA, EPITHELIAL GROWTH
FACTOR, ERYTHROCYTES,
FUMARIC ACID, FUNICULUS, GINGKO, HYALURONIDASE, IL 1 - BETA, KALUM
ASPARITICUM, MULTI B VITAMIN
COMPLEX (B 1,2,3,5,6,9,12), MUSCLE, NATRUM OXALACETICUM, NATRUM
PYRUVICUM, PLACENTA,
QUINHYDRONE, SUCCINIC ACID, SILICEA AND TRIFOLIUM INJECTION
VIATREXX BIO INCORPORATED
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
FACIAL
10ml
Rx
Sterile multi-dose injectable homeopathic vial
Isotonic saline with 1% Benzyl alcohol as a preservative.
For IV, IM, SC, Parenteral use.
Osmolarity around 0.3mOsmol/ml.
DES CRIPTION
VIATREXX-FACIAL is a homeopathic product composed of physiological
(low dose and low low dose)
natural micro nutrients. These nano particles are designed to nourish
the system.
INDICATIONS AND USE
VIATREXX-FACIALa sterile, injectable, biodegradable, clear isotonic
liquid that is injected into the various
layers of the skin, muscles, ligaments, joints, other body tissues or
added to an IV, either as a push or
into the bag.
CONTRAINDICATIONS
This product should not be used in patients with a known
hypersensitivity to any ingredient found in the
formula, porcine products, isotonic saline or benzyl alcohol, or
patients with a history of severe
allergies. As with all injections, epinephrine injection (1:1,000)
must be immediately available should an
acute anaphylactoid reaction occur due to any component of the
injection.
WARNINGS
Homeopathic injections are quite safe, but all medical procedures
carry some risk. The most common
risk is an allergic reaction to the injection of any ingredient found
in the formula, porcine, benzyl
alcohol &/or saline. Do not use if allergic to any of these
substances. Side effects include some risk of
bruising and temporary redness at the site of the injection. Use
appropriate emergency protocol if signs
of allergic reaction or infection appear, du
                                
                                Read the complete document